Your browser doesn't support javascript.
loading
Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy.
Cicconi, Laura; Breccia, Massimo; Franceschini, Luca; Latagliata, Roberto; Molica, Matteo; Divona, Mariadomenica; Diverio, Daniela; Rizzo, Manuela; Ottone, Tiziana; Iaccarino, Licia; Alfonso, Valentina; Foa, Robin; Voso, Maria Teresa; Lo-Coco, Francesco.
Afiliación
  • Cicconi L; Department of Biomedicine and Prevention, University Tor Vergata, via Montpellier,1, 00133, Rome, Italy. cicconi.laura@yahoo.it.
  • Breccia M; Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.
  • Franceschini L; Department of Biomedicine and Prevention, University Tor Vergata, via Montpellier,1, 00133, Rome, Italy.
  • Latagliata R; Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.
  • Molica M; Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.
  • Divona M; Policlinico Tor Vergata, Rome, Italy.
  • Diverio D; Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.
  • Rizzo M; Policlinico Tor Vergata, Rome, Italy.
  • Ottone T; Department of Biomedicine and Prevention, University Tor Vergata, via Montpellier,1, 00133, Rome, Italy.
  • Iaccarino L; Department of Biomedicine and Prevention, University Tor Vergata, via Montpellier,1, 00133, Rome, Italy.
  • Alfonso V; Department of Biomedicine and Prevention, University Tor Vergata, via Montpellier,1, 00133, Rome, Italy.
  • Foa R; Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.
  • Voso MT; Department of Biomedicine and Prevention, University Tor Vergata, via Montpellier,1, 00133, Rome, Italy.
  • Lo-Coco F; Department of Biomedicine and Prevention, University Tor Vergata, via Montpellier,1, 00133, Rome, Italy.
Ann Hematol ; 97(10): 1797-1802, 2018 Oct.
Article en En | MEDLINE | ID: mdl-29951912
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Promielocítica Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Promielocítica Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Italia